Full name
LEXFARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.62.Z - Retail sale of newspapers, periodicals, and paper articles
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.99.Z - Retail trade
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | 0 | 0 | 24,2 |
Gross profit (loss) | -0 | 0 | 0 | 161,1 |
EBITDA | -0 | 0 | 0 | 483,1 |
Short time liabilities | 0,2 | 0,2 | 0,3 | 42,9 |
Other operating costs | 0 | 0 | 0 | 7,1 |
Equity capital | 0,2 | 0,2 | 0,2 | 5,6 |
Operating profit (EBIT) | -0 | 0 | 0 | 162 |
Assets | 0,4 | 0,4 | 0,7 | 62,4 |
Net profit (loss) | -0 | 0 | 0 | 379,6 |
Cash | 0,1 | 0,1 | 0,1 | -21,8 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,5 | 121,9 |
Net income from sale | 2,1 | 2,3 | 2,7 | 20,4 |
Working assets | 0,4 | 0,4 | 0,5 | 17,3 |
Other income costs | 0 | 0 | 0 | 2288,7 |
Depreciation | 0 | 0 | 0 | 7748,8 |
% | % | % | p.p. | |
Profitability of capital | -1,4 | 1,2 | 5,3 | 4,1 |
Equity capital to total assets | 52,7 | 51,2 | 33,3 | -17,9 |
Gross profit margin | -0,1 | 0,3 | 0,6 | 0,3 |
EBITDA Margin | -0,1 | 0,3 | 1,3 | 1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 34 | 33 | 39 | 6 |
Current financial liquidity indicator | 1.9808269739151 | 1.9264310598373413 | 1.5817461013793945 | -0,3 |
Net dept to EBITDA | 54.141334533691406 | -18.6734676361084 | 2.138598918914795 | 20,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane